“…K-ras mutations are present in between 13% and 50% of ampullary carcinomas [9,33,34,35,36,37,38,39,40]. However, these studies are not completely comparable due to the number of cases included, ranging from two [36] to 93 [38]; the number of codons examined (in most of them only codon 12 was analyzed), and the materials and methods employed (DNA extraction from frozen vs. paraffin-embedded tissues, use of microdissection to enrich the neoplastic cell population, etc.).…”